Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinitis Pigmentosa | 77 | 2010 | 387 | 8.480 |
Why?
|
Eye Proteins | 37 | 2008 | 645 | 4.120 |
Why?
|
Retinoblastoma | 41 | 2020 | 317 | 2.980 |
Why?
|
Rhodopsin | 30 | 2009 | 205 | 2.620 |
Why?
|
Retinal Degeneration | 17 | 2019 | 422 | 2.040 |
Why?
|
Genes, Recessive | 27 | 2008 | 650 | 1.890 |
Why?
|
Macular Degeneration | 13 | 2023 | 981 | 1.800 |
Why?
|
Night Blindness | 13 | 2008 | 53 | 1.700 |
Why?
|
Mutation, Missense | 18 | 2010 | 2552 | 1.610 |
Why?
|
Genes, Dominant | 23 | 2009 | 883 | 1.590 |
Why?
|
Uveal Neoplasms | 6 | 2021 | 310 | 1.560 |
Why?
|
Photoreceptor Cells, Vertebrate | 11 | 2009 | 207 | 1.480 |
Why?
|
Electroretinography | 39 | 2009 | 511 | 1.470 |
Why?
|
Pedigree | 71 | 2008 | 4640 | 1.440 |
Why?
|
Point Mutation | 22 | 2005 | 1626 | 1.370 |
Why?
|
Choroidal Neovascularization | 6 | 2016 | 343 | 1.230 |
Why?
|
Eye Neoplasms | 27 | 2007 | 314 | 1.230 |
Why?
|
Retinal Neoplasms | 6 | 2020 | 143 | 1.140 |
Why?
|
Mutation | 65 | 2010 | 29658 | 1.130 |
Why?
|
Retinal Rod Photoreceptor Cells | 10 | 2008 | 201 | 0.980 |
Why?
|
Genes, Retinoblastoma | 12 | 2001 | 136 | 0.960 |
Why?
|
Chromosomes, Human, Pair 13 | 12 | 1999 | 198 | 0.920 |
Why?
|
Retinal Diseases | 10 | 2017 | 687 | 0.910 |
Why?
|
3',5'-Cyclic-GMP Phosphodiesterases | 7 | 1999 | 57 | 0.910 |
Why?
|
DNA Mutational Analysis | 29 | 2006 | 4182 | 0.910 |
Why?
|
Optic Atrophy, Hereditary, Leber | 4 | 2007 | 46 | 0.910 |
Why?
|
Blindness | 9 | 2008 | 613 | 0.870 |
Why?
|
Eye Diseases, Hereditary | 4 | 2005 | 117 | 0.870 |
Why?
|
Ciliary Body | 4 | 2021 | 173 | 0.820 |
Why?
|
Retina | 18 | 2023 | 2633 | 0.790 |
Why?
|
Frameshift Mutation | 5 | 2007 | 398 | 0.760 |
Why?
|
Extracellular Matrix Proteins | 6 | 2010 | 847 | 0.740 |
Why?
|
Complement System Proteins | 2 | 2021 | 799 | 0.720 |
Why?
|
Mixed Tumor, Mullerian | 1 | 2019 | 56 | 0.710 |
Why?
|
Polymorphism, Single-Stranded Conformational | 17 | 2003 | 335 | 0.710 |
Why?
|
Retinal Cone Photoreceptor Cells | 6 | 2008 | 179 | 0.710 |
Why?
|
Molecular Biology | 3 | 2020 | 594 | 0.700 |
Why?
|
Base Sequence | 48 | 2017 | 12804 | 0.680 |
Why?
|
Molecular Sequence Data | 56 | 2006 | 18125 | 0.680 |
Why?
|
Eye Infections | 1 | 2019 | 63 | 0.670 |
Why?
|
Pigment Epithelium of Eye | 10 | 2021 | 231 | 0.670 |
Why?
|
Cytogenetics | 1 | 2019 | 203 | 0.670 |
Why?
|
Alleles | 26 | 2017 | 6942 | 0.660 |
Why?
|
Cytogenetic Analysis | 1 | 2019 | 295 | 0.650 |
Why?
|
Heterozygote | 16 | 2017 | 2798 | 0.630 |
Why?
|
Genetic Linkage | 14 | 2001 | 2433 | 0.620 |
Why?
|
Visual Acuity | 22 | 2008 | 2517 | 0.620 |
Why?
|
Retinal Pigment Epithelium | 3 | 2023 | 302 | 0.600 |
Why?
|
Chromosomes, Human, Pair 10 | 2 | 2017 | 287 | 0.590 |
Why?
|
Orbital Neoplasms | 1 | 2019 | 226 | 0.580 |
Why?
|
Polymorphism, Restriction Fragment Length | 16 | 1993 | 769 | 0.560 |
Why?
|
Rhabdomyosarcoma | 1 | 2019 | 381 | 0.550 |
Why?
|
Sequence Analysis, DNA | 12 | 2019 | 4791 | 0.540 |
Why?
|
Fundus Oculi | 13 | 2014 | 473 | 0.540 |
Why?
|
Optic Atrophies, Hereditary | 3 | 2001 | 27 | 0.510 |
Why?
|
Haplotypes | 3 | 2017 | 2782 | 0.510 |
Why?
|
Chromosomes, Human, 13-15 | 12 | 1988 | 52 | 0.510 |
Why?
|
Photoreceptor Cells | 9 | 1998 | 254 | 0.510 |
Why?
|
Transducin | 7 | 2005 | 47 | 0.500 |
Why?
|
Codon, Nonsense | 2 | 2006 | 281 | 0.490 |
Why?
|
Amino Acid Sequence | 36 | 2005 | 13816 | 0.490 |
Why?
|
Rod Cell Outer Segment | 5 | 1997 | 59 | 0.470 |
Why?
|
Alcohol Oxidoreductases | 3 | 2008 | 170 | 0.470 |
Why?
|
Dark Adaptation | 15 | 2008 | 220 | 0.460 |
Why?
|
Retinaldehyde | 4 | 2004 | 25 | 0.450 |
Why?
|
Deafness | 4 | 2001 | 461 | 0.440 |
Why?
|
Proline | 6 | 2000 | 454 | 0.440 |
Why?
|
DNA Primers | 15 | 2008 | 2893 | 0.430 |
Why?
|
Laser Coagulation | 1 | 2014 | 326 | 0.420 |
Why?
|
Polymerase Chain Reaction | 22 | 2019 | 6174 | 0.420 |
Why?
|
Visual Fields | 17 | 2018 | 1049 | 0.410 |
Why?
|
Interleukin-17 | 2 | 2015 | 894 | 0.410 |
Why?
|
Rod Opsins | 7 | 1999 | 112 | 0.410 |
Why?
|
DNA | 25 | 2002 | 7275 | 0.410 |
Why?
|
Protein Kinases | 4 | 2004 | 1637 | 0.410 |
Why?
|
Chromosome Mapping | 24 | 2007 | 4743 | 0.400 |
Why?
|
Neoplasm Proteins | 2 | 2021 | 3694 | 0.400 |
Why?
|
Retinal Pigments | 4 | 2008 | 87 | 0.390 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 1994 | 0.390 |
Why?
|
Dry Eye Syndromes | 1 | 2015 | 382 | 0.380 |
Why?
|
Polymorphism, Genetic | 20 | 2006 | 4332 | 0.380 |
Why?
|
Physician Executives | 1 | 2012 | 128 | 0.380 |
Why?
|
Intermediate Filament Proteins | 4 | 1997 | 269 | 0.380 |
Why?
|
Membrane Proteins | 9 | 2017 | 7862 | 0.380 |
Why?
|
Rare Diseases | 2 | 2005 | 553 | 0.380 |
Why?
|
Eyelid Neoplasms | 3 | 2018 | 90 | 0.370 |
Why?
|
Exons | 17 | 2008 | 2430 | 0.370 |
Why?
|
Uterine Neoplasms | 1 | 2019 | 1511 | 0.370 |
Why?
|
Homozygote | 8 | 2017 | 1788 | 0.360 |
Why?
|
Interleukin-1beta | 1 | 2015 | 970 | 0.360 |
Why?
|
Paraneoplastic Syndromes | 2 | 2002 | 151 | 0.360 |
Why?
|
Genetic Counseling | 4 | 2020 | 601 | 0.360 |
Why?
|
Eye Diseases | 5 | 2006 | 670 | 0.360 |
Why?
|
Carrier Proteins | 6 | 2004 | 5012 | 0.360 |
Why?
|
Chromosome Deletion | 12 | 1996 | 1402 | 0.350 |
Why?
|
Genetic Heterogeneity | 4 | 2004 | 727 | 0.350 |
Why?
|
Humans | 208 | 2023 | 739398 | 0.350 |
Why?
|
IMP Dehydrogenase | 2 | 2005 | 34 | 0.330 |
Why?
|
Adenocarcinoma | 7 | 2021 | 6318 | 0.320 |
Why?
|
Female | 121 | 2023 | 378853 | 0.310 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 1999 | 366 | 0.300 |
Why?
|
Codon | 10 | 1999 | 613 | 0.300 |
Why?
|
GTP-Binding Protein beta Subunits | 1 | 2006 | 32 | 0.290 |
Why?
|
Male | 108 | 2023 | 349022 | 0.290 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2007 | 141 | 0.290 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2002 | 657 | 0.290 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3571 | 0.290 |
Why?
|
X Chromosome | 4 | 2000 | 815 | 0.280 |
Why?
|
Ion Channels | 2 | 2005 | 1056 | 0.270 |
Why?
|
Uniparental Disomy | 2 | 2002 | 43 | 0.270 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 3101 | 0.270 |
Why?
|
Ophthalmology | 1 | 2012 | 504 | 0.270 |
Why?
|
Acyltransferases | 1 | 2007 | 290 | 0.260 |
Why?
|
Spinocerebellar Ataxias | 2 | 2005 | 85 | 0.260 |
Why?
|
Color Vision Defects | 1 | 2005 | 28 | 0.260 |
Why?
|
Arrestin | 4 | 1998 | 30 | 0.260 |
Why?
|
Introns | 7 | 2006 | 992 | 0.250 |
Why?
|
Uveal Diseases | 3 | 2002 | 45 | 0.250 |
Why?
|
Melanoma | 6 | 2020 | 5446 | 0.240 |
Why?
|
Nerve Tissue Proteins | 6 | 2002 | 4463 | 0.240 |
Why?
|
Syndrome | 7 | 2005 | 3241 | 0.240 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4189 | 0.240 |
Why?
|
Vision, Ocular | 3 | 2008 | 471 | 0.240 |
Why?
|
Homeodomain Proteins | 3 | 2002 | 2409 | 0.240 |
Why?
|
Proteins | 4 | 2017 | 6082 | 0.240 |
Why?
|
Corneal Dystrophies, Hereditary | 2 | 2005 | 80 | 0.240 |
Why?
|
RGS Proteins | 1 | 2004 | 78 | 0.230 |
Why?
|
Melanocytes | 4 | 2002 | 514 | 0.230 |
Why?
|
Trans-Activators | 3 | 2002 | 2922 | 0.230 |
Why?
|
Phosphoproteins | 4 | 2004 | 2440 | 0.230 |
Why?
|
Adenoma, Pleomorphic | 1 | 2004 | 75 | 0.230 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2005 | 217 | 0.220 |
Why?
|
Telomere | 1 | 2009 | 907 | 0.220 |
Why?
|
Oncogenes | 7 | 1990 | 1264 | 0.220 |
Why?
|
Optic Disk Drusen | 1 | 2023 | 35 | 0.220 |
Why?
|
Gene Frequency | 5 | 2008 | 3585 | 0.220 |
Why?
|
Adult | 64 | 2021 | 213394 | 0.210 |
Why?
|
Carboxylesterase | 5 | 1986 | 31 | 0.210 |
Why?
|
Leadership | 1 | 2012 | 1349 | 0.210 |
Why?
|
Sodium-Calcium Exchanger | 1 | 2002 | 91 | 0.210 |
Why?
|
Glaucoma, Open-Angle | 2 | 2019 | 706 | 0.210 |
Why?
|
Endometrial Neoplasms | 2 | 2002 | 1351 | 0.200 |
Why?
|
Complement Pathway, Alternative | 2 | 2021 | 126 | 0.200 |
Why?
|
Keratoconus | 1 | 2023 | 119 | 0.200 |
Why?
|
Adaptation, Ocular | 2 | 1999 | 93 | 0.200 |
Why?
|
Apolipoproteins E | 1 | 2007 | 1437 | 0.190 |
Why?
|
Antibodies, Monoclonal | 2 | 2015 | 9259 | 0.190 |
Why?
|
Cloning, Molecular | 14 | 2019 | 4319 | 0.190 |
Why?
|
Macula Lutea | 1 | 2001 | 151 | 0.190 |
Why?
|
Choroid | 3 | 2021 | 319 | 0.190 |
Why?
|
Genetic Testing | 6 | 2020 | 3441 | 0.180 |
Why?
|
Vision Disorders | 2 | 2007 | 1058 | 0.180 |
Why?
|
Gelsolin | 1 | 2001 | 190 | 0.180 |
Why?
|
Vitreous Body | 3 | 1999 | 389 | 0.180 |
Why?
|
Retinol-Binding Proteins | 2 | 2008 | 65 | 0.180 |
Why?
|
Middle Aged | 52 | 2021 | 212863 | 0.180 |
Why?
|
Isoenzymes | 3 | 1999 | 1720 | 0.180 |
Why?
|
Germ-Line Mutation | 2 | 1998 | 1786 | 0.180 |
Why?
|
Penetrance | 2 | 1999 | 381 | 0.170 |
Why?
|
Gene Expression Regulation | 3 | 2017 | 12049 | 0.170 |
Why?
|
Complement Activation | 1 | 2021 | 451 | 0.170 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2019 | 97 | 0.170 |
Why?
|
Corneal Transplantation | 1 | 2023 | 368 | 0.170 |
Why?
|
Complement Factor H | 3 | 2008 | 110 | 0.170 |
Why?
|
Calcium Channel Blockers | 2 | 2019 | 686 | 0.170 |
Why?
|
Myosins | 1 | 2000 | 408 | 0.170 |
Why?
|
Gene Expression | 8 | 2006 | 7788 | 0.170 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 862 | 0.160 |
Why?
|
Hidrocystoma | 1 | 2018 | 11 | 0.160 |
Why?
|
Carboxylic Ester Hydrolases | 5 | 1986 | 99 | 0.160 |
Why?
|
Ophthalmoplegia | 1 | 2019 | 166 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 4 | 2017 | 17384 | 0.160 |
Why?
|
Complement Factor D | 1 | 2018 | 67 | 0.160 |
Why?
|
Ataxia | 1 | 2000 | 299 | 0.160 |
Why?
|
DNA-Binding Proteins | 5 | 2004 | 9622 | 0.160 |
Why?
|
DNA, Ribosomal | 1 | 2019 | 288 | 0.160 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2001 | 562 | 0.160 |
Why?
|
Diagnosis, Differential | 7 | 2020 | 12948 | 0.160 |
Why?
|
Iris | 7 | 1982 | 239 | 0.160 |
Why?
|
Amino Acid Substitution | 4 | 2007 | 1793 | 0.160 |
Why?
|
Hyaluronic Acid | 2 | 2018 | 486 | 0.160 |
Why?
|
DNA, Fungal | 1 | 2019 | 277 | 0.160 |
Why?
|
Epidermal Cyst | 1 | 2018 | 62 | 0.150 |
Why?
|
Sweat Gland Neoplasms | 2 | 2018 | 108 | 0.150 |
Why?
|
Vestibular Diseases | 1 | 2000 | 218 | 0.150 |
Why?
|
Linkage Disequilibrium | 4 | 2017 | 1992 | 0.150 |
Why?
|
Laurence-Moon Syndrome | 1 | 1997 | 8 | 0.150 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 1999 | 417 | 0.150 |
Why?
|
Osteosarcoma | 4 | 1989 | 884 | 0.150 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2002 | 485 | 0.150 |
Why?
|
Prolactinoma | 1 | 2018 | 113 | 0.150 |
Why?
|
Fluorescein Angiography | 5 | 2014 | 939 | 0.150 |
Why?
|
Calcium-Binding Proteins | 2 | 2004 | 1078 | 0.150 |
Why?
|
Fatal Outcome | 4 | 2002 | 1850 | 0.150 |
Why?
|
Aqueous Humor | 1 | 2017 | 163 | 0.140 |
Why?
|
Trabecular Meshwork | 1 | 2017 | 98 | 0.140 |
Why?
|
Genotype | 9 | 2008 | 12951 | 0.140 |
Why?
|
Restriction Mapping | 6 | 1994 | 879 | 0.140 |
Why?
|
Loss of Heterozygosity | 1 | 1999 | 678 | 0.140 |
Why?
|
Cosmetic Techniques | 1 | 2018 | 133 | 0.140 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 6 | 4 | 1999 | 30 | 0.140 |
Why?
|
Sex Chromosome Aberrations | 1 | 1996 | 114 | 0.140 |
Why?
|
Orbit | 1 | 2019 | 425 | 0.140 |
Why?
|
Amyloid Neuropathies | 1 | 1995 | 15 | 0.140 |
Why?
|
Oculomotor Muscles | 1 | 2019 | 355 | 0.140 |
Why?
|
Protein Structure, Secondary | 2 | 1997 | 1245 | 0.140 |
Why?
|
Aged | 35 | 2021 | 162698 | 0.140 |
Why?
|
Membrane Glycoproteins | 4 | 1997 | 3768 | 0.140 |
Why?
|
Microsatellite Repeats | 4 | 2007 | 797 | 0.140 |
Why?
|
Lymphoma, B-Cell | 1 | 2002 | 929 | 0.130 |
Why?
|
Recombination, Genetic | 4 | 1999 | 1591 | 0.130 |
Why?
|
Adolescent | 28 | 2015 | 85405 | 0.130 |
Why?
|
Cattle | 10 | 2017 | 3913 | 0.130 |
Why?
|
Mosaicism | 1 | 1998 | 442 | 0.130 |
Why?
|
Gene Deletion | 2 | 2001 | 2757 | 0.130 |
Why?
|
Genes, Tumor Suppressor | 1 | 2019 | 1096 | 0.130 |
Why?
|
Valine | 2 | 2000 | 413 | 0.130 |
Why?
|
Intraocular Pressure | 2 | 2018 | 1261 | 0.130 |
Why?
|
Genetics, Medical | 1 | 1997 | 340 | 0.120 |
Why?
|
Protein Kinase C | 1 | 1999 | 1223 | 0.120 |
Why?
|
RNA, Messenger | 7 | 2021 | 13002 | 0.120 |
Why?
|
Wet Macular Degeneration | 1 | 2016 | 146 | 0.120 |
Why?
|
Tears | 1 | 2015 | 252 | 0.120 |
Why?
|
Transcription Factors | 3 | 2017 | 12120 | 0.120 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1467 | 0.120 |
Why?
|
Prealbumin | 1 | 1995 | 209 | 0.120 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 1991 | 1088 | 0.120 |
Why?
|
Testis | 1 | 2017 | 799 | 0.120 |
Why?
|
Promoter Regions, Genetic | 6 | 2008 | 5863 | 0.120 |
Why?
|
Retinal Detachment | 3 | 2006 | 408 | 0.120 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2017 | 664 | 0.110 |
Why?
|
G-Protein-Coupled Receptor Kinase 1 | 3 | 1997 | 8 | 0.110 |
Why?
|
Injections, Intravenous | 1 | 2015 | 1421 | 0.110 |
Why?
|
Child | 23 | 2008 | 77033 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2017 | 2901 | 0.110 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 2 | 2004 | 154 | 0.110 |
Why?
|
Amyloidosis | 1 | 2019 | 789 | 0.110 |
Why?
|
Drugs, Generic | 1 | 2018 | 423 | 0.110 |
Why?
|
Genetic Markers | 6 | 1997 | 2630 | 0.110 |
Why?
|
Serine | 1 | 1996 | 831 | 0.110 |
Why?
|
Transforming Growth Factor beta | 1 | 2001 | 1997 | 0.110 |
Why?
|
Chromosomes, Human, X | 2 | 2005 | 296 | 0.110 |
Why?
|
Histidine | 2 | 2008 | 313 | 0.110 |
Why?
|
Perfusion | 1 | 2017 | 1354 | 0.110 |
Why?
|
Genetic Diseases, Inborn | 1 | 1997 | 588 | 0.110 |
Why?
|
Immunohistochemistry | 3 | 2021 | 11347 | 0.110 |
Why?
|
Ovary | 1 | 2017 | 982 | 0.110 |
Why?
|
Aged, 80 and over | 16 | 2019 | 57650 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3863 | 0.110 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 1993 | 198 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 1999 | 1214 | 0.100 |
Why?
|
Lipoproteins | 1 | 1997 | 880 | 0.100 |
Why?
|
Genetic Diseases, X-Linked | 2 | 2007 | 370 | 0.100 |
Why?
|
Smoking | 3 | 2007 | 8960 | 0.100 |
Why?
|
Nevus, Pigmented | 2 | 2006 | 218 | 0.100 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2002 | 1592 | 0.100 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 2 | 2005 | 37 | 0.100 |
Why?
|
Darkness | 4 | 1995 | 167 | 0.100 |
Why?
|
Autoantibodies | 1 | 2019 | 2020 | 0.100 |
Why?
|
Animals | 34 | 2023 | 168368 | 0.100 |
Why?
|
Models, Animal | 1 | 2018 | 2164 | 0.100 |
Why?
|
Binding Sites | 3 | 2017 | 6113 | 0.100 |
Why?
|
Sp1 Transcription Factor | 1 | 1991 | 144 | 0.100 |
Why?
|
Complement Factor B | 2 | 2023 | 72 | 0.100 |
Why?
|
Prescription Drugs | 1 | 2018 | 594 | 0.100 |
Why?
|
Amyloid | 1 | 1995 | 794 | 0.090 |
Why?
|
Phenotype | 9 | 2005 | 16301 | 0.090 |
Why?
|
DNA, Neoplasm | 6 | 1991 | 1754 | 0.090 |
Why?
|
Lacrimal Apparatus | 1 | 1992 | 224 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2019 | 1849 | 0.090 |
Why?
|
Disease Models, Animal | 6 | 2017 | 18003 | 0.090 |
Why?
|
Mice | 21 | 2023 | 81002 | 0.090 |
Why?
|
Receptors, Cell Surface | 1 | 1999 | 2864 | 0.090 |
Why?
|
Usher Syndromes | 1 | 2010 | 50 | 0.090 |
Why?
|
Monophenol Monooxygenase | 3 | 1984 | 70 | 0.090 |
Why?
|
Vitamin A | 2 | 2006 | 613 | 0.090 |
Why?
|
Catechol Oxidase | 2 | 1980 | 2 | 0.090 |
Why?
|
Collagen | 1 | 2018 | 2671 | 0.090 |
Why?
|
Clinical Trials as Topic | 1 | 2005 | 7897 | 0.090 |
Why?
|
Hybrid Cells | 6 | 1996 | 441 | 0.090 |
Why?
|
Leucine | 1 | 1991 | 560 | 0.090 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1334 | 0.090 |
Why?
|
Blotting, Southern | 6 | 1997 | 803 | 0.090 |
Why?
|
Methionine | 2 | 1991 | 591 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2017 | 15500 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 4743 | 0.080 |
Why?
|
Antigens | 2 | 1995 | 1462 | 0.080 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2005 | 2833 | 0.080 |
Why?
|
Glaucoma | 2 | 2017 | 1140 | 0.080 |
Why?
|
3' Untranslated Regions | 2 | 2008 | 508 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 1 | 2017 | 3770 | 0.080 |
Why?
|
Antibodies, Neutralizing | 1 | 2018 | 1957 | 0.080 |
Why?
|
Cell Line | 10 | 2006 | 15987 | 0.080 |
Why?
|
Microtubule-Associated Proteins | 2 | 2005 | 1082 | 0.080 |
Why?
|
Chromosomes, Human, 1-3 | 2 | 1986 | 23 | 0.080 |
Why?
|
Retinitis | 1 | 2007 | 35 | 0.080 |
Why?
|
Citric Acid Cycle | 1 | 2008 | 230 | 0.080 |
Why?
|
Retinoblastoma Protein | 5 | 1999 | 700 | 0.070 |
Why?
|
Lod Score | 4 | 1997 | 615 | 0.070 |
Why?
|
Scleral Diseases | 1 | 2007 | 22 | 0.070 |
Why?
|
Uveitis | 1 | 2010 | 377 | 0.070 |
Why?
|
DNA Probes | 3 | 1994 | 561 | 0.070 |
Why?
|
Choroid Neoplasms | 3 | 2003 | 175 | 0.070 |
Why?
|
Myofibroma | 1 | 2007 | 51 | 0.070 |
Why?
|
DNA Restriction Enzymes | 6 | 1986 | 570 | 0.070 |
Why?
|
Chromosome Aberrations | 2 | 1991 | 1812 | 0.070 |
Why?
|
Blood Proteins | 1 | 1991 | 1122 | 0.070 |
Why?
|
Retrospective Studies | 9 | 2023 | 76631 | 0.070 |
Why?
|
Oligodeoxyribonucleotides | 3 | 1993 | 708 | 0.070 |
Why?
|
Intravitreal Injections | 2 | 2018 | 345 | 0.070 |
Why?
|
Hearing Loss | 2 | 2004 | 759 | 0.070 |
Why?
|
Light | 3 | 2004 | 1380 | 0.070 |
Why?
|
Phosphenes | 1 | 2006 | 44 | 0.070 |
Why?
|
DNA, Complementary | 2 | 2002 | 2049 | 0.070 |
Why?
|
Optic Nerve Neoplasms | 1 | 2006 | 44 | 0.070 |
Why?
|
Sequence Alignment | 3 | 2005 | 2256 | 0.070 |
Why?
|
Tyrosine | 2 | 2008 | 1460 | 0.070 |
Why?
|
Repetitive Sequences, Nucleic Acid | 3 | 1995 | 794 | 0.070 |
Why?
|
Photic Stimulation | 3 | 2008 | 2032 | 0.070 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 3 | 1990 | 170 | 0.070 |
Why?
|
Mitochondrial Encephalomyopathies | 1 | 2005 | 37 | 0.070 |
Why?
|
Conjunctival Diseases | 1 | 2006 | 121 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2006 | 3922 | 0.070 |
Why?
|
Pyridines | 1 | 2017 | 2810 | 0.070 |
Why?
|
Cytoskeletal Proteins | 2 | 2001 | 1369 | 0.060 |
Why?
|
Disease Progression | 3 | 2019 | 13237 | 0.060 |
Why?
|
Siblings | 2 | 2007 | 853 | 0.060 |
Why?
|
Cornea | 2 | 2023 | 1488 | 0.060 |
Why?
|
Nucleic Acid Hybridization | 3 | 1985 | 1372 | 0.060 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 1 | 2005 | 93 | 0.060 |
Why?
|
Skin Neoplasms | 2 | 2004 | 5632 | 0.060 |
Why?
|
NAD | 1 | 2008 | 591 | 0.060 |
Why?
|
Molecular Epidemiology | 1 | 2007 | 469 | 0.060 |
Why?
|
Consensus Sequence | 1 | 2005 | 378 | 0.060 |
Why?
|
GTP-Binding Protein Regulators | 1 | 2004 | 13 | 0.060 |
Why?
|
Granuloma | 1 | 2006 | 313 | 0.060 |
Why?
|
DNA, Satellite | 2 | 1994 | 67 | 0.060 |
Why?
|
Microscopy, Electron | 4 | 1998 | 2665 | 0.060 |
Why?
|
Eye | 2 | 1979 | 731 | 0.060 |
Why?
|
Double-Blind Method | 2 | 2015 | 11985 | 0.060 |
Why?
|
Sound | 1 | 2006 | 259 | 0.060 |
Why?
|
Guanylate Cyclase | 1 | 2004 | 200 | 0.060 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 1998 | 380 | 0.060 |
Why?
|
Contrast Sensitivity | 1 | 2005 | 244 | 0.060 |
Why?
|
Transfection | 5 | 2002 | 5884 | 0.060 |
Why?
|
Mice, Inbred C57BL | 3 | 2018 | 21863 | 0.060 |
Why?
|
Models, Structural | 2 | 1995 | 361 | 0.060 |
Why?
|
Hyperopia | 1 | 2003 | 44 | 0.060 |
Why?
|
Refractive Errors | 1 | 2005 | 142 | 0.060 |
Why?
|
Orphan Nuclear Receptors | 1 | 2003 | 60 | 0.060 |
Why?
|
Osteoma | 1 | 2003 | 13 | 0.060 |
Why?
|
Chromosome Banding | 4 | 1995 | 278 | 0.060 |
Why?
|
Hallucinations | 1 | 2006 | 359 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 3504 | 0.060 |
Why?
|
Temporal Arteries | 1 | 2004 | 128 | 0.060 |
Why?
|
Rabbits | 3 | 2018 | 4882 | 0.060 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2008 | 869 | 0.060 |
Why?
|
Open Reading Frames | 2 | 2003 | 810 | 0.050 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2005 | 419 | 0.050 |
Why?
|
Dolphins | 1 | 2002 | 14 | 0.050 |
Why?
|
Visual Field Tests | 2 | 2006 | 378 | 0.050 |
Why?
|
Fatty Acid Transport Proteins | 1 | 2002 | 32 | 0.050 |
Why?
|
Macromolecular Substances | 2 | 1995 | 1457 | 0.050 |
Why?
|
Glutamine | 2 | 2008 | 574 | 0.050 |
Why?
|
Psoriasis | 1 | 2010 | 888 | 0.050 |
Why?
|
Keratoplasty, Penetrating | 1 | 2023 | 151 | 0.050 |
Why?
|
Glycine | 2 | 2008 | 674 | 0.050 |
Why?
|
Serine Endopeptidases | 1 | 2007 | 1070 | 0.050 |
Why?
|
Eye Enucleation | 2 | 2006 | 129 | 0.050 |
Why?
|
Gene Library | 2 | 2002 | 1077 | 0.050 |
Why?
|
Genomic Library | 1 | 2002 | 192 | 0.050 |
Why?
|
Vitamin E | 1 | 2006 | 870 | 0.050 |
Why?
|
Antibodies | 1 | 2010 | 2450 | 0.050 |
Why?
|
Amino Acid Motifs | 1 | 2004 | 940 | 0.050 |
Why?
|
Leucine Zippers | 1 | 2002 | 117 | 0.050 |
Why?
|
Environment | 1 | 2008 | 1110 | 0.050 |
Why?
|
Cysteine | 1 | 2006 | 870 | 0.050 |
Why?
|
Uvea | 2 | 1978 | 31 | 0.050 |
Why?
|
Optic Disk | 1 | 2006 | 402 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2004 | 2910 | 0.050 |
Why?
|
Neoplasms, Multiple Primary | 1 | 1986 | 599 | 0.050 |
Why?
|
DNA, Single-Stranded | 2 | 1993 | 351 | 0.050 |
Why?
|
Catalytic Domain | 1 | 2004 | 698 | 0.050 |
Why?
|
Risk Factors | 7 | 2017 | 71974 | 0.050 |
Why?
|
Sarcoidosis | 1 | 2006 | 507 | 0.050 |
Why?
|
Carcinoma | 2 | 1992 | 2361 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2007 | 2974 | 0.050 |
Why?
|
Protein Conformation | 2 | 2004 | 4012 | 0.050 |
Why?
|
Vitamins | 2 | 2006 | 1602 | 0.050 |
Why?
|
Geographic Atrophy | 1 | 2021 | 66 | 0.050 |
Why?
|
Vitrectomy | 3 | 2003 | 358 | 0.050 |
Why?
|
Autopsy | 2 | 2021 | 1004 | 0.050 |
Why?
|
Mice, Mutant Strains | 3 | 1994 | 1883 | 0.050 |
Why?
|
Genetic Variation | 2 | 2006 | 6539 | 0.050 |
Why?
|
Ophthalmoscopy | 2 | 2008 | 176 | 0.050 |
Why?
|
Odds Ratio | 2 | 2018 | 9846 | 0.050 |
Why?
|
Uterine Hemorrhage | 1 | 2002 | 255 | 0.050 |
Why?
|
Docosahexaenoic Acids | 1 | 2006 | 873 | 0.050 |
Why?
|
Glaucoma, Angle-Closure | 1 | 2002 | 182 | 0.050 |
Why?
|
Oligonucleotide Probes | 2 | 1991 | 425 | 0.040 |
Why?
|
GTP-Binding Proteins | 2 | 2003 | 972 | 0.040 |
Why?
|
Karyotyping | 6 | 1990 | 1241 | 0.040 |
Why?
|
Mice, Transgenic | 4 | 1998 | 9734 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 28901 | 0.040 |
Why?
|
Oxygen | 2 | 2001 | 4158 | 0.040 |
Why?
|
Blotting, Northern | 2 | 1991 | 1583 | 0.040 |
Why?
|
Injections, Intraocular | 1 | 2018 | 30 | 0.040 |
Why?
|
Consanguinity | 2 | 2008 | 456 | 0.040 |
Why?
|
Child, Preschool | 10 | 2007 | 40802 | 0.040 |
Why?
|
Laminin | 1 | 2000 | 418 | 0.040 |
Why?
|
Apocrine Glands | 1 | 2018 | 31 | 0.040 |
Why?
|
Cysteinyldopa | 1 | 1977 | 1 | 0.040 |
Why?
|
cis-trans-Isomerases | 1 | 1998 | 44 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1999 | 426 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2008 | 3848 | 0.040 |
Why?
|
Eccrine Glands | 1 | 2018 | 45 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10534 | 0.040 |
Why?
|
Dihydroxyphenylalanine | 1 | 1977 | 76 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 1991 | 8400 | 0.040 |
Why?
|
New England | 1 | 2001 | 1021 | 0.040 |
Why?
|
Sympathetic Nervous System | 1 | 1980 | 514 | 0.040 |
Why?
|
Thymidine Kinase | 2 | 1990 | 292 | 0.040 |
Why?
|
Chloride Channels | 1 | 1999 | 225 | 0.040 |
Why?
|
Recoverin | 1 | 1997 | 13 | 0.040 |
Why?
|
Hippocalcin | 1 | 1997 | 8 | 0.040 |
Why?
|
Hyperplasia | 1 | 2001 | 1181 | 0.040 |
Why?
|
Lacrimal Apparatus Diseases | 2 | 1992 | 65 | 0.040 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 1999 | 463 | 0.040 |
Why?
|
Injections, Intraperitoneal | 1 | 2018 | 423 | 0.040 |
Why?
|
Paternal Age | 1 | 1997 | 84 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2000 | 706 | 0.040 |
Why?
|
Tonometry, Ocular | 1 | 2018 | 237 | 0.040 |
Why?
|
Adaptation, Physiological | 1 | 2004 | 1310 | 0.040 |
Why?
|
Melanins | 1 | 1979 | 290 | 0.040 |
Why?
|
Medicare Part B | 1 | 2018 | 108 | 0.040 |
Why?
|
Nuclear Family | 1 | 1998 | 318 | 0.040 |
Why?
|
Carcinoma, Adenoid Cystic | 3 | 1992 | 253 | 0.040 |
Why?
|
C-Reactive Protein | 1 | 2008 | 3752 | 0.040 |
Why?
|
Leukocytes | 2 | 1998 | 2035 | 0.040 |
Why?
|
Sensory Thresholds | 3 | 2008 | 395 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2014 | 19811 | 0.030 |
Why?
|
Biomedical Research | 1 | 2012 | 3301 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2002 | 1783 | 0.030 |
Why?
|
Half-Life | 1 | 2017 | 658 | 0.030 |
Why?
|
Complement C3 | 1 | 2018 | 460 | 0.030 |
Why?
|
Histones | 1 | 2006 | 2591 | 0.030 |
Why?
|
Cataract | 1 | 2002 | 825 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2003 | 1383 | 0.030 |
Why?
|
Hair | 1 | 1979 | 479 | 0.030 |
Why?
|
Endothelin-1 | 1 | 2017 | 313 | 0.030 |
Why?
|
Cell Survival | 1 | 2005 | 5877 | 0.030 |
Why?
|
Computer-Aided Design | 1 | 2017 | 298 | 0.030 |
Why?
|
Tomography, Optical Coherence | 4 | 2008 | 2623 | 0.030 |
Why?
|
Arthritis, Rheumatoid | 1 | 2010 | 3689 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2017 | 911 | 0.030 |
Why?
|
Chromosome Disorders | 2 | 1991 | 516 | 0.030 |
Why?
|
Blotting, Western | 2 | 2018 | 5181 | 0.030 |
Why?
|
Fathers | 1 | 1997 | 357 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1996 | 956 | 0.030 |
Why?
|
Signal Transduction | 2 | 1995 | 23355 | 0.030 |
Why?
|
Menarche | 1 | 1977 | 513 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2004 | 1721 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2018 | 560 | 0.030 |
Why?
|
Choroid Diseases | 1 | 1994 | 66 | 0.030 |
Why?
|
Down-Regulation | 1 | 2001 | 2999 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1995 | 404 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2008 | 21694 | 0.030 |
Why?
|
Retinal Dysplasia | 1 | 1993 | 15 | 0.030 |
Why?
|
Mitosis | 1 | 1999 | 1212 | 0.030 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 1994 | 322 | 0.030 |
Why?
|
Axons | 1 | 2001 | 1689 | 0.030 |
Why?
|
Mutagenesis | 1 | 1997 | 1265 | 0.030 |
Why?
|
Poly A | 1 | 1993 | 185 | 0.030 |
Why?
|
Models, Molecular | 1 | 2004 | 5460 | 0.030 |
Why?
|
DNA, Recombinant | 2 | 1984 | 475 | 0.030 |
Why?
|
Young Adult | 3 | 2015 | 56255 | 0.030 |
Why?
|
Ultrasonography | 2 | 2006 | 5941 | 0.030 |
Why?
|
Iron | 1 | 2001 | 1776 | 0.030 |
Why?
|
United States | 4 | 2019 | 69573 | 0.030 |
Why?
|
Genes, Regulator | 1 | 1994 | 378 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2018 | 720 | 0.030 |
Why?
|
Cell Division | 1 | 2001 | 4575 | 0.030 |
Why?
|
Gene Amplification | 2 | 1989 | 1061 | 0.030 |
Why?
|
Chromosomes, Human, Pair 17 | 2 | 1991 | 438 | 0.030 |
Why?
|
Conserved Sequence | 1 | 1996 | 1203 | 0.030 |
Why?
|
Calcium | 2 | 2004 | 5742 | 0.030 |
Why?
|
Apoptosis | 1 | 2009 | 9714 | 0.030 |
Why?
|
Dog Diseases | 1 | 1993 | 136 | 0.030 |
Why?
|
Up-Regulation | 1 | 2001 | 4205 | 0.030 |
Why?
|
Sequence Deletion | 1 | 1997 | 1528 | 0.030 |
Why?
|
Adenoviruses, Human | 1 | 1994 | 258 | 0.030 |
Why?
|
Biopsy | 2 | 2019 | 6722 | 0.030 |
Why?
|
Activating Transcription Factors | 1 | 1991 | 29 | 0.030 |
Why?
|
Reference Values | 1 | 1999 | 4983 | 0.030 |
Why?
|
Evaluation Studies as Topic | 1 | 1994 | 1676 | 0.020 |
Why?
|
Choroideremia | 1 | 1990 | 25 | 0.020 |
Why?
|
RNA Splicing | 1 | 1995 | 904 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 1996 | 1967 | 0.020 |
Why?
|
Rats | 3 | 2002 | 24270 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2018 | 2208 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2006 | 9812 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 1993 | 913 | 0.020 |
Why?
|
Adenovirus Early Proteins | 1 | 1989 | 57 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2019 | 2039 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 1999 | 1373 | 0.020 |
Why?
|
Cohort Studies | 4 | 2010 | 40389 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2001 | 3433 | 0.020 |
Why?
|
Oligonucleotides, Antisense | 1 | 1991 | 432 | 0.020 |
Why?
|
Isocitrates | 1 | 2008 | 24 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 1990 | 323 | 0.020 |
Why?
|
Equipment Design | 1 | 2017 | 3583 | 0.020 |
Why?
|
Enzyme Activation | 1 | 1995 | 3701 | 0.020 |
Why?
|
Gene Transfer Techniques | 1 | 1994 | 1227 | 0.020 |
Why?
|
Hypopigmentation | 1 | 2008 | 41 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1995 | 2634 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6516 | 0.020 |
Why?
|
Lymphocytes | 3 | 2008 | 2612 | 0.020 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1989 | 257 | 0.020 |
Why?
|
Methylation | 1 | 1991 | 1106 | 0.020 |
Why?
|
Dogs | 1 | 1993 | 3915 | 0.020 |
Why?
|
Suppression, Genetic | 1 | 1988 | 196 | 0.020 |
Why?
|
NADP | 1 | 2008 | 225 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2002 | 5830 | 0.020 |
Why?
|
Infant | 8 | 2001 | 34923 | 0.020 |
Why?
|
Models, Genetic | 1 | 1997 | 3493 | 0.020 |
Why?
|
Age Factors | 2 | 2001 | 18349 | 0.020 |
Why?
|
Oncogene Proteins, Viral | 1 | 1989 | 362 | 0.020 |
Why?
|
Neuropeptides | 1 | 1993 | 942 | 0.020 |
Why?
|
Retinal Vessels | 1 | 1992 | 774 | 0.020 |
Why?
|
Swine | 1 | 2017 | 5901 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2019 | 2836 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2019 | 2861 | 0.020 |
Why?
|
Angiogenesis Inhibitors | 1 | 2017 | 2037 | 0.020 |
Why?
|
Pyrazoles | 1 | 2017 | 1963 | 0.020 |
Why?
|
Tryptophan | 1 | 2008 | 477 | 0.020 |
Why?
|
Plasmids | 2 | 1989 | 2307 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 1991 | 1178 | 0.020 |
Why?
|
Glucocorticoids | 2 | 2006 | 2100 | 0.020 |
Why?
|
Placebos | 1 | 2010 | 1678 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1995 | 6610 | 0.020 |
Why?
|
Time Factors | 2 | 2007 | 40050 | 0.020 |
Why?
|
Germ Cells | 1 | 1989 | 627 | 0.020 |
Why?
|
Genetic Techniques | 1 | 1988 | 436 | 0.020 |
Why?
|
Guanylate Cyclase-Activating Proteins | 1 | 2004 | 3 | 0.020 |
Why?
|
Disease Susceptibility | 2 | 1989 | 1778 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2010 | 1725 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9387 | 0.020 |
Why?
|
Androstadienes | 1 | 2006 | 340 | 0.020 |
Why?
|
Arginine | 1 | 2008 | 945 | 0.020 |
Why?
|
Middle East | 1 | 2005 | 219 | 0.020 |
Why?
|
Administration, Topical | 1 | 2006 | 687 | 0.020 |
Why?
|
Albinism | 1 | 1984 | 27 | 0.020 |
Why?
|
Eye Color | 1 | 2004 | 39 | 0.020 |
Why?
|
Computational Biology | 2 | 2010 | 3506 | 0.020 |
Why?
|
Cricetinae | 2 | 1991 | 2468 | 0.020 |
Why?
|
Genetic Vectors | 1 | 1994 | 3419 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2001 | 5128 | 0.020 |
Why?
|
Ultraviolet Rays | 3 | 1990 | 1059 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 1990 | 3510 | 0.010 |
Why?
|
Phosphorylation | 1 | 1995 | 8416 | 0.010 |
Why?
|
Necrosis | 2 | 2003 | 1643 | 0.010 |
Why?
|
Matched-Pair Analysis | 1 | 2004 | 289 | 0.010 |
Why?
|
Species Specificity | 2 | 2002 | 2480 | 0.010 |
Why?
|
DNA Methylation | 1 | 1997 | 4269 | 0.010 |
Why?
|
Demography | 1 | 2008 | 1650 | 0.010 |
Why?
|
Vision Tests | 1 | 1984 | 167 | 0.010 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2007 | 578 | 0.010 |
Why?
|
Protein Binding | 1 | 1995 | 9375 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7690 | 0.010 |
Why?
|
Polymethyl Methacrylate | 1 | 2003 | 145 | 0.010 |
Why?
|
Sweden | 1 | 2005 | 1336 | 0.010 |
Why?
|
Fovea Centralis | 1 | 2003 | 119 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2004 | 691 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 1800 | 0.010 |
Why?
|
Autoradiography | 1 | 1983 | 765 | 0.010 |
Why?
|
Cell Membrane | 1 | 1991 | 3747 | 0.010 |
Why?
|
Trisomy | 1 | 1983 | 264 | 0.010 |
Why?
|
Infant, Newborn | 3 | 1996 | 25470 | 0.010 |
Why?
|
Acoustic Stimulation | 1 | 2006 | 1216 | 0.010 |
Why?
|
Occupational Diseases | 2 | 1980 | 1474 | 0.010 |
Why?
|
Genome, Human | 1 | 1994 | 4419 | 0.010 |
Why?
|
Rodentia | 1 | 1983 | 260 | 0.010 |
Why?
|
Medicare | 1 | 2019 | 6497 | 0.010 |
Why?
|
Japan | 1 | 2005 | 1348 | 0.010 |
Why?
|
Horner Syndrome | 1 | 1980 | 37 | 0.010 |
Why?
|
Epithelium, Corneal | 1 | 2003 | 240 | 0.010 |
Why?
|
Cytological Techniques | 1 | 1982 | 216 | 0.010 |
Why?
|
Epidemiologic Research Design | 1 | 2004 | 368 | 0.010 |
Why?
|
Transcription, Genetic | 2 | 1991 | 7709 | 0.010 |
Why?
|
Pigmentation | 1 | 1980 | 150 | 0.010 |
Why?
|
Giant Cell Arteritis | 1 | 2004 | 291 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2006 | 2602 | 0.010 |
Why?
|
Cell Nucleus | 1 | 1989 | 2965 | 0.010 |
Why?
|
Sampling Studies | 1 | 2001 | 624 | 0.010 |
Why?
|
HIV Infections | 1 | 2006 | 16764 | 0.010 |
Why?
|
Follow-Up Studies | 3 | 2008 | 38942 | 0.010 |
Why?
|
Keratitis | 1 | 2003 | 268 | 0.010 |
Why?
|
Chemical Industry | 1 | 1980 | 114 | 0.010 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 2 | 1982 | 480 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20055 | 0.010 |
Why?
|
Conjunctiva | 1 | 2003 | 493 | 0.010 |
Why?
|
Neuroglia | 1 | 1985 | 928 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 35326 | 0.010 |
Why?
|
Prednisone | 1 | 2004 | 1560 | 0.010 |
Why?
|
Ophthalmia, Sympathetic | 1 | 1979 | 16 | 0.010 |
Why?
|
China | 1 | 2005 | 2225 | 0.010 |
Why?
|
Forecasting | 1 | 1988 | 2952 | 0.010 |
Why?
|
Electrooculography | 1 | 1998 | 118 | 0.010 |
Why?
|
Sulfur | 1 | 1979 | 164 | 0.010 |
Why?
|
Regression Analysis | 1 | 2008 | 6452 | 0.010 |
Why?
|
Epithelium | 1 | 2003 | 1684 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 1999 | 8791 | 0.010 |
Why?
|
Device Removal | 1 | 2003 | 648 | 0.010 |
Why?
|
Diterpenes | 1 | 1998 | 174 | 0.010 |
Why?
|
Color | 1 | 1979 | 304 | 0.010 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2006 | 1896 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23294 | 0.010 |
Why?
|
X-Rays | 2 | 1990 | 300 | 0.010 |
Why?
|
France | 1 | 1998 | 516 | 0.010 |
Why?
|
Eye Injuries | 1 | 1980 | 241 | 0.010 |
Why?
|
Corneal Diseases | 1 | 2003 | 600 | 0.010 |
Why?
|
Models, Biological | 1 | 1993 | 9609 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2003 | 2110 | 0.010 |
Why?
|
Educational Status | 1 | 2004 | 2514 | 0.010 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 1999 | 640 | 0.010 |
Why?
|
Defective Viruses | 1 | 1994 | 112 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 1994 | 6310 | 0.010 |
Why?
|
Lac Operon | 1 | 1994 | 238 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 1999 | 1771 | 0.010 |
Why?
|
Survival Analysis | 1 | 2007 | 10247 | 0.010 |
Why?
|
Reoperation | 1 | 2003 | 4192 | 0.010 |
Why?
|
Histocytochemistry | 1 | 1994 | 723 | 0.010 |
Why?
|
Methotrexate | 1 | 1999 | 1711 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2004 | 2116 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2002 | 2748 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2004 | 3945 | 0.010 |
Why?
|
Cells, Cultured | 3 | 1998 | 19220 | 0.010 |
Why?
|
Dopamine | 1 | 1977 | 1597 | 0.010 |
Why?
|
Sex Factors | 1 | 2004 | 10398 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1994 | 1549 | 0.010 |
Why?
|
Family | 1 | 2000 | 3141 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1995 | 3146 | 0.010 |
Why?
|
Mutagens | 1 | 1990 | 168 | 0.010 |
Why?
|
Cricetulus | 1 | 1991 | 814 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2010 | 62693 | 0.010 |
Why?
|
Organelles | 1 | 1989 | 270 | 0.000 |
Why?
|
Genes | 1 | 1991 | 1898 | 0.000 |
Why?
|
Mitomycins | 1 | 1986 | 47 | 0.000 |
Why?
|
Clone Cells | 1 | 1990 | 1685 | 0.000 |
Why?
|
Body Mass Index | 1 | 2004 | 12655 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 14740 | 0.000 |
Why?
|
Mitomycin | 1 | 1986 | 259 | 0.000 |
Why?
|
Neoplasm Transplantation | 1 | 1989 | 2084 | 0.000 |
Why?
|
Mice, Inbred BALB C | 1 | 1994 | 6397 | 0.000 |
Why?
|
Epidemiologic Methods | 2 | 1980 | 1364 | 0.000 |
Why?
|
Leukemia, Lymphoid | 1 | 1984 | 313 | 0.000 |
Why?
|
Cytoplasm | 1 | 1989 | 1536 | 0.000 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 1985 | 526 | 0.000 |
Why?
|
Nystagmus, Pathologic | 1 | 1984 | 96 | 0.000 |
Why?
|
Esotropia | 1 | 1984 | 81 | 0.000 |
Why?
|
Environmental Exposure | 1 | 1977 | 4220 | 0.000 |
Why?
|
Liver | 1 | 1998 | 7449 | 0.000 |
Why?
|
Mice, Nude | 1 | 1989 | 3692 | 0.000 |
Why?
|
Protein Biosynthesis | 1 | 1990 | 2131 | 0.000 |
Why?
|
Adenoma, Sweat Gland | 1 | 1982 | 18 | 0.000 |
Why?
|
Cystadenoma | 1 | 1982 | 84 | 0.000 |
Why?
|
Immunoenzyme Techniques | 1 | 1985 | 1801 | 0.000 |
Why?
|
West Virginia | 1 | 1980 | 28 | 0.000 |
Why?
|
Calcinosis | 1 | 1989 | 1493 | 0.000 |
Why?
|
Staining and Labeling | 1 | 1984 | 1108 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2004 | 11699 | 0.000 |
Why?
|
Microspheres | 1 | 1982 | 778 | 0.000 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1989 | 2936 | 0.000 |
Why?
|
Brain | 1 | 2006 | 26345 | 0.000 |
Why?
|
Translocation, Genetic | 1 | 1984 | 1416 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2004 | 15070 | 0.000 |
Why?
|
Nevus | 1 | 1980 | 203 | 0.000 |
Why?
|
Astrocytes | 1 | 1985 | 1258 | 0.000 |
Why?
|
Incidence | 1 | 1995 | 20913 | 0.000 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 1980 | 343 | 0.000 |
Why?
|
Functional Laterality | 1 | 1983 | 2291 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1984 | 5959 | 0.000 |
Why?
|
B-Lymphocytes | 1 | 1986 | 4663 | 0.000 |
Why?
|
Adenoma | 1 | 1982 | 2167 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1980 | 4832 | 0.000 |
Why?
|